To include your compound in the COVID-19 Resource Center, submit it here.

Boehringer, Anthem begin real-world COPD trial

Boehringer Ingelheim GmbH (Ingelheim, Germany) and Anthem Inc. (NYSE:ANTM) and its outcomes research subsidiary HealthCore Inc. have begun enrolling patients in a real-world

Read the full 230 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE